p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trialAmir Sonnenblick, Christos Sotiriou|International Journal of Oncology|2017Cited by 21
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancerHeba Alkhatib, Nataly Kravchenko‐Balasha, Sangita Roy Chowdhury et al.|Molecular Cancer|2024Cited by 12